Healthcare provider profile · identity verified

Ken T. Yang, MD

Family Practice · CLINTON, NC · NPI 1912935180

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	494	126
Furosemide	Furosemide	341	96
Amlodipine Besylate	Amlodipine Besylate	340	83
Metoprolol Succinate	Metoprolol Succinate	244	60
Enalapril Maleate	Enalapril Maleate	203	62
Pantoprazole Sodium	Pantoprazole Sodium	171	48
Levothyroxine Sodium	Levothyroxine Sodium	170	41
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	162	22
Losartan Potassium	Losartan Potassium	160	38
Eliquis	Apixaban	156	37
Alprazolam	Alprazolam	152	22
Meloxicam	Meloxicam	152	39
Omeprazole	Omeprazole	149	44
Lovastatin	Lovastatin	142	40
Metformin Hcl Er	Metformin Hcl	142	40
Potassium Chloride	Potassium Chloride	140	39
Ozempic	Semaglutide	138	21
Prednisone	Prednisone	135	113
Gabapentin	Gabapentin	129	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	123	33
Carvedilol	Carvedilol	115	34
Clopidogrel	Clopidogrel Bisulfate	115	23
Rosuvastatin Calcium	Rosuvastatin Calcium	114	33
Hydrochlorothiazide	Hydrochlorothiazide	110	33
Methylprednisolone	Methylprednisolone	110	104
Tamsulosin Hcl	Tamsulosin Hcl	107	32
Metoprolol Tartrate	Metoprolol Tartrate	98	23
Fluticasone Propionate	Fluticasone Propionate	92	24
Azithromycin	Azithromycin	89	84
Allopurinol	Allopurinol	85	22
Ezetimibe	Ezetimibe	77	15
Jardiance	Empagliflozin	75	12
Albuterol Sulfate Hfa	Albuterol Sulfate	74	28
Baclofen	Baclofen	73	47
Citalopram Hbr	Citalopram Hydrobromide	71	16
Spironolactone	Spironolactone	70	21
Glipizide Er	Glipizide	69	20
Trulicity	Dulaglutide	67	16
Lisinopril	Lisinopril	62	19
Simvastatin	Simvastatin	61	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	61	57
Levofloxacin	Levofloxacin	60	56
Naproxen	Naproxen	60	26
Hydralazine Hcl	Hydralazine Hcl	59	17
Trazodone Hcl	Trazodone Hcl	58	17
Cefdinir	Cefdinir	57	54
Xarelto	Rivaroxaban	55	12
Ropinirole Hcl	Ropinirole Hcl	52	suppressed
Amoxicillin	Amoxicillin	51	47
Atenolol	Atenolol	51	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	50	suppressed
Levetiracetam	Levetiracetam	49	suppressed
Montelukast Sodium	Montelukast Sodium	49	15
Ibuprofen	Ibuprofen	48	20
Zolpidem Tartrate	Zolpidem Tartrate	48	12
Doxazosin Mesylate	Doxazosin Mesylate	46	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	46	13
Alendronate Sodium	Alendronate Sodium	45	13
Metformin Hcl	Metformin Hcl	41	16
Hydroxyzine Hcl	Hydroxyzine Hcl	40	suppressed
Dexamethasone	Dexamethasone	38	38
Tramadol Hcl	Tramadol Hcl	37	23
Triamcinolone Acetonide	Triamcinolone Acetonide	37	27
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Meclizine Hcl	Meclizine Hcl	36	20
Bumetanide	Bumetanide	35	11
Sertraline Hcl	Sertraline Hcl	35	suppressed
Colchicine	Colchicine	33	suppressed
Famotidine	Famotidine	33	suppressed
Fluconazole	Fluconazole	33	24
Amitriptyline Hcl	Amitriptyline Hcl	32	11
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Januvia	Sitagliptin Phosphate	32	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Mupirocin	Mupirocin	31	25
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	12
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Sucralfate	Sucralfate	27	13
Clonidine Hcl	Clonidine Hcl	24	suppressed
Ketoconazole	Ketoconazole	24	14
Minocycline Hcl	Minocycline Hcl	24	24
Chlorthalidone	Chlorthalidone	23	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	22	21
Klor-Con M20	Potassium Chloride	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Repatha Sureclick	Evolocumab	21	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	21	suppressed
Cilostazol	Cilostazol	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	19
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Ondansetron Odt	Ondansetron	19	13
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Aliskiren	Aliskiren Hemifumarate	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Promethazine Hcl	Promethazine Hcl	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Cefadroxil	Cefadroxil	16	16
Diltiazem Hcl	Diltiazem Hcl	16	suppressed
Metolazone	Metolazone	16	suppressed
Primidone	Primidone	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Nabumetone	Nabumetone	15	suppressed
Retacrit	Epoetin Alfa-Epbx	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Valsartan	Valsartan	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Estradiol	Estradiol	13	suppressed
Finasteride	Finasteride	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Albuterol Sulfate	Albuterol Sulfate	12	suppressed
Diazepam	Diazepam	12	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	12	suppressed
Humulin R	Insulin Regular, Human	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Torsemide	Torsemide	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Digoxin	Digoxin	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	11	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error